The current status of heart transplantation and the development of artificial heart systems;Situation der herztransplantation und weiterentwicklung von kunstherzen

Deutsches Arzteblatt

Volumn 106, Issue 28-29, 2009, Pages 471-477

  Strüber, Martin ^a   Meyer, Anna L ^a   Malehsa, Doris ^a   Kugler, Christiane ^a   Simon, Andre R ^a   Haverich, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Artificial heart; Heart failure; Heart transplantation; Quality of life; Transplantation statistics

Indexed keywords

ALTERNATIVE MEDICINE; COMPARATIVE STUDY; GERMANY; HEART; HEART GRAFT; HOSPITAL ADMISSION; MEDICAL LITERATURE; QUALITY OF LIFE; REVIEW;

EQUIPMENT DESIGN; GERMANY; HEART FAILURE; HEART TRANSPLANTATION; HEART, ARTIFICIAL; HUMANS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 70349225756     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2009.0471     Document Type: Review

References (25)

1. Komoda T, Hetzer R, Lehmkuhl HB: Destiny of candidates for heart transplantation in the Eurotransplant heart allocation system. Eur J Cardiothor Surg 2008; 34: 301-306
2. Strüber M, Sander K, Lahpor J et al.: HeartMate II left ventricular assist device; early European experience. Eur J Cardiothoracic Surg 2008; 34: 289-294
3. Cooley DA: The total artificial heart. Nature Medicine 2003; 9: 108-111
4. Bücherl ES, Henning E, Baer P, Frank J, Lamm W, Zartnack F: Status of the Artificial Heart Program in Berlin.World J Surg 1985; 9: 103-115
5. Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD: Orthotopic Cardiac Prosthesis for Two-Staged Cardiac Replacement. A J Cardiologie 1969; 24: 723-730
6. Pennington DG, Kanter KR, McBride LR et al.: Seven years experience with the Pierce-Donachy ventricular assist device. J Thorac Cardiovasc Surg 1988; 96: 9014-9021
7. Pennington DG, Reedy JE, Swartz MT et al.: Univentricular versus biventricular assist device support. J Heart Lung Transplant 1991; 10: 258-263
8. Frazier OH: First use of an untethered, vented electric left ventricular assist device for long term support. Circulation 1994; 89: 2908-2914
9. Vetter HO, Kaulbach HG, Schmitz C et al.: Experience with the Novacor left ventricular assist System as a bridge to cardiac transplantation, including a new wearable system. J Thorac Cardiovasc Surg 1995; 109: 74-80.
10. Rose EA, Moskowitz AJ, Heitjan DF et al.: Long term mechanical left ventricular assistance for end stage heart failure. N Engl J Med 2001; 345: 1434-1443
11. Rothenburger M, Wilhelm MJ, Hammel D et al.: Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation 2002; 106: (Suppl 1) I189-92.
12. Miller LW, Pagani FD, Russell SD et al.: Use of continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007; 357: 885-896
13. Esmore D, Spratt P, Larbalestier R et al.: VentrAssist left ventricular assist device: clinical trial results and Clinical Development Plan update. Eur J Cardiothorac Surg 2007; 32: 735-744 (Pubitemid 47513516)
14. Wieselthaler GM, Riedl M, Schima H et al.: Endocrine function is not impaired in patients with a continuous MircoMed-DeBakey axial flow pump. J Thorac Cardiovasc Surg 2007; 133: 2-6. (Pubitemid 46014193)
15. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH: End-organ function in patients on long term circulatory support with continuous - or pulsatile - flow assist devices. J Heart Lung Transplant 2007; 26: 815-818 (Pubitemid 47199072)
16. Zimpfer D, Wieselthaler G, Czerny M et al.: Neurocognitive function in patients with ventricular assist devices: a comparison of pulsatile and continuous blood flow devices. Asaio J 2006; 52: 24-27 (Pubitemid 44314893)
17. Akimoto T, Yamazaki K, Litwak P et al.: Rotary blood pump flow spontaneously increases during exercise under constant pump speed: results of a chronic study. Artif Organs 1999; 23: 797-801. (Pubitemid 29383327)
18. Geisen U, Heilmann C, Beyersdorf F et al.: Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008; 33: 679-684
19. Lietz K, Long JW, Kfoury AG et al.: Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: Implications for patient selection. Circulation 2007; 116: 497-505. (Pubitemid 47450258)
20. Potapov EV, Loforte A,Weng Y et al.: Experience with over 1000 implanted ventricular assist devices. J Card Surg 2008; 23: 185-194 (Pubitemid 351589424)
21. Osaki S, Edwards NM, Velez M et al.: Improved survival in patients with ventricular assist device therapy: the University of Wisconsin experience. Eur J Cardiothor Surg 2008; 35: 281-288
22. Pruijsten RV, Jonge N de, Kirkels JH et al.: Left ventricular assist device: a functional comparison with heart transplantation. Neth Heart J 2008; 16: 41-46 (Pubitemid 351230942)
23. Tegtbur U, Busse MW, Jung K, Pethig K, Haverich A: Time course of physical reconditioning during exercise rehabilitation late after heart transplantation. J Heart Lung Transplant 2005; 24: 270-274 (Pubitemid 40312050)
24. Mercier JG, Hokanson JF, Brooks GA: Effects of cyclosporine A on skeletal muscle mitochondrial respiration and endurance time in rats. Am J Respir Crit Care Med 1995; 151: 1532-1536
25. Pae WE, Connell JM, Adelowo A et al.: Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant 2007; 26: 219-229 (Pubitemid 46341881)